The Mercury Medical Investments (MMI) group provides early stage funding for promising healthcare and healthcare related technology.
We identify investments aligned with our mission to improve healthcare and patient outcomes through innovation and technology, while striving to achieve excellent returns for our investors.
Once identified and screened, we seed the early stage companies and provide financing, guidance, and networking to help the venture achieve benchmarks to success.
MMI group assists companies looking to secure funding from $50K to $1M. We can assist in securing all or part of the funds needed for success.
We support investments that improve healthcare and patient outcomes through innovation and technology.
In line with our mission, we invest in medical devices (diagnostic, therapeutic, and cosmetic), pharmaceuticals, medical education technologies and services, health information technologies, and research technologies.
Mercury Medical Investments is comprised of a group of partners with extensive experience in angel investing, operations management, and non-profit incorporation. In addition, several of our partners are board certified physicians with extensive clinical practices and research affiliations through various universities. We have built deep relationships with medical clinicians in a variety of medical specialties. As a result, we are uniquely positioned to help support and develop early and middle stage medical startup ventures.
Current Projects
Therevant Corporation
Theravant produces light and energy based devices that treat an array of cosmetic issues. We are working with them to expand their markets, increase revenue, and establish their primary sales channels.
Integrix
Integrix is an IT company whose primary current focus is a web based enterprise resource plan that is used by dermatologists to maintain their inventory of pharmaceutical cosmetics, track their sales generate customer loyalty programs, marketing tool.
MARS
MARS (Mohs Automated Reporting System) is an IT company dedicated to providing a low cost electronic medical records product specifically tailored to meet the needs of MOHS (skin cancer) surgeons as well as track information for use in larger clinical studies.
Vedaderm
Vedaderm is a pharmaceutical company based in India with proprietary cosmetic pharmaceuticals as well as medical pharmaceuticals. Our group has helped them build and refine their cosmetic pharmaceutical line and achieve profitability over a three year period. We are continuing to support them as they build their sales channels.
The materials will be reviewed by our Screening Committee. Companies with selected proposals will be notified and asked to prepare a 15 minute in-person presentation for the group with a 2 week notice period.
